key: cord-0902282-n76inyi8
authors: Wear, Martin A.; Patterson, Alan; Malone, Kirk; Dunsmore, Colin; Turner, Nicholas J.; Walkinshaw, Malcolm D.
title: A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A
date: 2005-10-15
journal: Anal Biochem
DOI: 10.1016/j.ab.2005.06.037
sha: 5daa5ef3f12ae1df45f5c1d91f2d98465a30a72b
doc_id: 902282
cord_uid: n76inyi8

A simple protocol for generating a highly stable and active surface plasmon resonance (SPR) sensor surface of recombinant human hexahistidine cyclophilin A (His-CypA) is described. The sensor surface was sensitive and stable enough to allow, for the first time, the screening and ranking of several novel small-molecule (M(r) ∼250–500 Da) ligands in a competition binding assay with cyclosporin A (CsA). It also allowed us to accurately determine the kinetic rate constants for the interaction between His-CypA and CsA. His-CypA was first captured on a Ni(2+)–nitrilotriacetic acid (NTA) sensor chip and was then briefly covalently stabilized, coupling via primary amines. The significant baseline drift observed due to dissociation of weakly bound His-CypA from the Ni(2+)–NTA moiety was eliminated, resulting in a surface that was stable for at least 36 h. In addition, immobilized protein activity levels were high, typically between 85 and 95%, assayed by the interaction between His-CypA and CsA. The mean equilibrium dissociation constant for CsA (K(dCsA)) binding to the immobilized His-CypA was 23 ± 6 nM, with on and off rates of 0.53 ± 0.1 μM(−1) s(−1) and 1.2 ± 0.1 (×10(−2)) s(−1), respectively. These values agree well with the values for the corresponding binding constants determined from steady-state and kinetic fluorescence titrations in solution.

Surface plasmon resonance (SPR) 1 is now a technique exploited regularly in the determination of equilibrium binding and kinetic rate constants of biomolecular interactions [1] [2] [3] [4] . It is also increasingly useful in drug discovery/hit validation studies with small molecules [4] [5] [6] [7] [8] [9] [10] [11] . A prerequisite for measuring the binding constants of an interaction by SPR is that the surface-immobilized molecule must be both stably attached and highly active. Most immobilization procedures are reliant on direct covalent linkage of a purified protein to chemically activated sensor surfaces. Such procedures generate stable surfaces. However, a significant proportion of proteins are not compatible with either the solution conditions or the surface chemistry used. As a result, many biomolecules have very low activity, or often become completely inactive, on immobilization. Over and above the loss of activity due to modification of critical residues involved in binding sites, the essentially random orientation resulting from covalent coupling leads to subpopulations of immobilized molecules that are incorrectly oriented for binding. There are a number of capture methods available (e.g., antibodies, biotinylation, oligohistidine tags) that can be used as alternatives to direct covalent coupling. However, the sensor surface often has a relatively low binding capacity and/or exhibits significant baseline drift due to the relatively weakly bound captured molecule dissociating from the surface. For example, single hexahistidine-tagged proteins captured on Ni 2+ -nitrilotriacetic acid (NTA) sensor surfaces have K d values in the low micromolar range [12] . Such leaching makes it difficult to assess binding kinetics accurately.

Here, we describe the generation of a highly stable and active sensor surface of an N-terminally tagged hexahistidine cyclophilin A (His-CypA), which has enabled a series of ligand binding studies with nonpeptide small molecules to be performed. The cyclophilins [13] have emerged recently as a potential drug target for a several diseases, including HIV and malaria infection [14, 15] . The SPR-based binding assay described here provides the basis of a screen for novel small-molecule cyclophilin inhibitors of potential therapeutic interest. The in vivo role of human cyclophilin A (CypA) is poorly understood, but its ability to enhance the rate of folding (or unfolding) of proteins via its peptidyl-prolyl isomerase (PPIase) activity is likely to be important, particularly when the cell is stressed [13, 16] . CypA was isolated as a complex with the immunosuppressive cyclic undecapeptide cyclosporin A (CsA) [17] , which is used as a therapy for preventing organ rejection following transplants. CsA acts by complex formation with cytosolic CypA, followed by binding and inhibition of the phosphatase calcineurin, blocking the signal transduction pathway for immunostimulation [18] . Previous work has identified many cyclosporin derivatives as CypA inhibitors [19] [20] [21] [22] [23] [24] [25] , but there are very few published examples that characterize nonpeptide inhibitor binding [26, 27] .

The development of an SPR-based assay for screening small-molecule ligands requires a stable and sensitive CypA sensor surface. Human CypA is not readily amenable to direct covalent immobilization on a CM5 sensor, or on a streptavidin (SA) sensor, using standard coupling chemistries. In our hands, these coupling protocols generated surfaces with very low levels of protein activity, typically only approximately 5%. Surfaces with such low levels of activity are neither active nor sensitive enough to facilitate the detection of small molecules. Although interactions between CypA, directly coupled to the sensor surface, and protein binding partners analyzed by SPR have been published [28] [29] [30] , the activity of immobilized protein and the sensitivity of the sensor required to detect binding of these much larger molecules are significantly less than those needed to detect smallmolecule ligands. In contrast, when His-CypA was first captured and oriented via its N-terminal hexahistidine tag on an NTA sensor surface and then was briefly covalently stabilized, using standard chemistries to activate the surface and couple via primary amines, the baseline drift was completely eliminated and the surface activity levels typically were in excess of 85%. These sensor surfaces allowed us, for the first time, to assess and rank the equilibrium dissociation constants (K d ) for several new small-molecule ($300-500 Da) inhibitors of CypA.

All chemicals used were of the highest grade available commercially.

The plasmids for expression of recombinant human CypA were created by polymerase chain reaction (PCR) using a whole tissue human lung cDNA library (Stratagene) as a template, with 5 0 -CCATGGTCAA CCCCACCGTGTTC-3 0 as the forward primer and 5 0 -GGATCCTTATTCGAGTTGTCCACAGTC-3 0 as the reverse primer. The resulting PCR product was verified by sequencing in both directions, using ABI PRISM BigDye v3 Terminator Cycle Sequencing Ready Reaction Kit and an ABI PRISM 310 genetic analyzer (Applied Biosystems). For generation of the untagged CypA expression vector, pSW3-001, the PCR product was digested with NcoI and BamHI (New England Bio-Labs) and then ligated into a pET-5a vector (Novagen) digested with NcoI and BamHI. For generation of the N-terminal His-CypA expression vector, pSW3-002, the NcoI and BamHI digested PCR product was ligated into a pET-15b vector (Novagen) similarly digested. Correct insertion of the coding region of CypA was verified by restriction digest and by sequencing the entire coding region in both directions.

All purification was performed on Å KTA Prime (Pharmacia) equipment at 4°C.

Recombinant human His-CypA was expressed and purified to homogeneity from BL21 (DE3) Escherichia coli (Novagen). LB media containing carbenicillin (100 lg ml À1 ) were grown shaking (260 rpm) at 37°C until the A 600nm was approximately 0.6. Overexpression of His-CypA was induced by the addition of isopropylthiogalactoside (IPTG) to 1 mM and growth for a further 3 h at 37°C. Lysis and purification, on NTA agarose resin (Qiagen), was performed according to standard protocols. Fractions containing His-CypA were pooled, concentrated to 61 ml, filtered through a 0.2-lm filter, and loaded onto a Sephacryl 200 HR (Pharmacia) gel filtration column (V t $ 1.6 · 60 cm) preequilibrated in 25 mM Tris (pH 7.5), 100 mM NaCl, 0.5 mM dithiothreitol (DTT), 0.5 mM ethylenediamine tetraacetic acid (EDTA), and 1 mM NaN 3 . His-CypA was more than 95% pure as judged by SDS-PAGE.

Recombinant human CypA was expressed and purified to homogeneity from BL21 Star (DE3) E. coli (Invitrogen). 2 · TY liquid media containing carbenicillin (100 lg ml À1 ) was grown at 37°C until the A 600nm was approximately 0.6. Overexpression of CypA was induced by the addition of IPTG to 1 mM and growth for a further 3 h at 37°C. Cells were harvested by centrifugation (3000g for 15 min) and washed once in 100 ml of lysis buffer (50 mM Hepes [pH 7.5], 1 mM DTT, 2.5 mM EDTA, 1 mM NaN 3 ). The cell pellet was resuspended at 10% weight per volume in ice-cold lysis buffer plus excess protease inhibitor cocktail (Sigma) and sonicated on ice for 6 · 30-s bursts with 30 s cooling in between. The cell lysate was subjected to centrifugation at 50,000g for 1 h at 4°C. The high-speed supernatant was dialyzed exhaustively overnight against 50 mM Hepes (pH 6.8), 1 mM DTT, 2.5 mM EDTA, 1 mM NaN 3 , 100 lM phenylmethanesulfonyl fluoride (PMSF), and 100 lM benzamidine; filtered through a 0.2-lm filter; and applied to an SP Sepharose (Pharmacia) column (V t $ 50 ml, 2.6 · 10 cm) preequilibrated in the same buffer. Proteins were eluted with a 0-to 400-mM NaCl gradient in the same buffer over 200 ml and were analyzed by SDS-PAGE. Fractions containing CypA, eluting between 130 and 160 mM NaCl, were pooled, concentrated to approximately 1 ml, filtered through a 0.2-lm filter, and loaded onto a Sephacryl 200 HR gel filtration column (V t $ 120 ml, 1.6 · 60 cm) preequilibrated in 25 mM Tris (pH 7.5), 100 mM NaCl, 0.5 mM DTT, 0.5 mM EDTA, and 1 mM NaN 3 . CypA was more than 95% pure as judged by SDS-PAGE.

SPR measurements were performed on a Biacore 3000 instrument kindly provided on loan from Biacore. Research-grade CM5, SA, and NTA sensors were used. The reagents 1-ethyl-3-(3-diaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were purchased from Biacore and used according to recommended protocols.

Pure His-CypA was immobilized on an NTA sensor chip. The sensor was primed and loaded with Ni 2+ according to BiacoreÕs recommended protocols. His-CypA in 10 mM Hepes (pH 7.4), 150 mM NaCl, 0.005% surfactant P20, and 2% ethanol, at concentrations between 200 nM and 1 lM, was passed over the sensor surface at a flow rate of 5 ll min À1 . Following saturation of the response units (RU) signal, a 30-s injection (at 15 ll min À1 ) of a mixture of NHS (115 mg ml À1 ) and EDC (750 mg ml À1 ), followed immediately followed by a 30-s injection (at 15 ll min À1 ) of 1 M ethanolamine (pH 8.5), was performed. The final amount of His-CypA covalently immobilized on the surface was typically between 850 and 1600 RU.

Pure CypA was immobilized on a CM5 sensor chip. HBS-EP2 buffer (10 mM Hepes [pH 7.4], 150 mM NaCl, 3 mM EDTA, 0.005% surfactant P20, 2% ethanol) was used as running buffer. Activation of the sensor chip surface was performed with a mixture of NHS (115 mg ml À1 ) and EDC (750 mg ml À1 ) for 7 min at 5 ll min À1 . CypA was diluted with 10 mM acetate buffer (pH 4.9) to a final concentration of between 10 and 50 lg ml À1 . The amount of CypA immobilized on the activated surface was controlled by altering the contact time of the protein solution and was between approximately 1000 and 5000 RU. After the immobilization of the protein, a 7-min injection (at 5 ll min À1 ) of 1 M ethanolamine (pH 8.5) was used to quench excess active succinimide ester groups.

Pure CypA was biotinylated using the EZ Link NHS-LC-Biotin kit (Pierce) according to recommended protocols. The protein was then immobilized on an SA sensor chip, according to BiacoreÕs recommended protocols, in HBS-EP2 buffer at 5 ll min À1 . The final amount of Bio-CypA covalently immobilized on the SA surface was 1811 RU.

SPR binding experiments with CsA were performed in HBS-EP2 buffer as the running buffer. The flow rate was 50 ll min À1 in all experiments. The sensor surface was regenerated between experiments by dissociating any formed complex in HBS-EP2 buffer for 30 min, followed by a further 30-min stabilization period. CypA is not amenable to more stringent and rapid regeneration conditions (data not shown). Furthermore, CsA is a hydrophobic molecule with limited solubility in aqueous solutions and has a tendency to adhere to tubing and tips at concentrations greater than 1.2 lM. Ethanol (2%) was used in experimental running buffers to help alleviate solubility problems. Ethanol was used in preference to dimethyl sulfoxide (DMSO) because this binds weakly to CypA [31] . The 60-min total regeneration time between experiments helped to eliminate any carryover of CsA [32] . A concentration series of CsA ranging from 0.5 nM to 1.2 lM was typically run in these experiments. The binding curves were analyzed for a one-to-one Langmuir binding model provided by with the Biacore 3000 instrument software.

SPR competition experiments were performed in HBS-EP2 buffer. A fixed concentration (25 nM) of CsA in the presence of increasing concentrations of the respective small molecule was passed over a covalently stabilized His-CypA sensor surface for 5 min at 50 ll min À1 . The sensor surface was regenerated between experiments by dissociating any formed complex in HBS-EP2 buffer for 30 min, followed by a further 30-min stabilization period. The binding curves were analyzed using the heterogeneous analyte competition model (i.e., CsA and the small molecule compete for the same single binding site on CypA) supplied with the Biacore 3000 instrument software, where the onand off-rate constants for CsA over the particular surface were predetermined and fixed for the fitting process.

CypA possesses a single tryptophan residue (Trp121) that is near ($9 Å ) the substrate proline binding pocket of the active site. The structure of CsA bound to CypA shows a strong H-bonded interaction between Trp121 and the carbonyl oxygen of MeLeu9 in CsA [33] . In addition to this interaction contributing significantly to the binding affinity and specificity of CsA for CypA, it accounts for the spectral changes in the fluorescence of Trp121 observed on complex formation [34] . Binding of CsA produces an enhancement of approximately two-to threefold and roughly an 8-nm blue shift in the tryptophan emission maxima (from 350 to 242 nm). Fluorescence emission spectra for CypA and His-CypA were obtained on a PTI Quantmaster spectrofluorometer (Photon Technology International) in a 3-ml cuvette at 25°C under constant gentle stirring. Tryptophan fluorescence was excited at 295 nm (5 nm bandpass), and emission was measured at 342 nm (5 nm bandpass). CypA (0.2-1 lM) was incubated in the absence or presence of increasing amounts of CsA in 25 mM Tris (pH 7.5), 100 mM NaCl, 1-2% ethanol, and 1 mM NaN 3 for 60 min at 25°C, and the emission spectra were measured.

We assumed that any change in the fluorescence signal at 342 nm is proportional to the concentration of CypA:ligand complex. The observed fluorescence was buffer background subtracted and corrected for dilution and inner filter effects by Eq. (1):

where f corr is the corrected fluorescence signal, f obs is the observed fluorescence signal, e 295nm is the ligand extinction coefficient at 295 nm (CsA, 985 M À1 cm À1 ), L is the path length (in this case 0.5 cm), and [Lig] is the molar ligand concentration. The corrected fluorescence signal, f corr (in arbitrary units), on complex formation can be defined as

ð2Þ The data were least squares fit to Eq. (3) using Kaleidagraph v3.6 software (Synergy Software):

Determination of kinetic rate constants for CsA binding to CypA The interaction of CsA and CypA was followed by monitoring the enhancement in the intrinsic tryptophan fluorescence of CypA (reported in arbitrary units) at 25°C in a 3-ml cuvette under constant gentle stirring on a PTI Quantmaster spectrofluorometer, with excitation at 295 nm and emission at 342 nm (5 nm slit width for both). CypA was used at a final concentration of 0.25 lM in 25 mM Tris (pH 7.5), 100 mM NaCl, 0.5 mM DTT, 0.5 mM EDTA, and 1% ethanol. Various concentrations of CsA were added to the CypA mixture, and the solution was mixed and placed in the fluorometer with a total dead time of approximately 3 s. The onand off-rate constants (k +CsA and k ÀCsA , respectively) were determined by fitting the fluorescence enhancement at 342 nm as a function of time to reaction 1, indicated below, and least squares minimization fitting of the data using version 8.01 of the Berkeley Madonna package. CsA is the CsA concentration and CypA is the concentration of recombinant human CypA:

If a second nonfluorescent ligand, [LigB] , that has negligible effect on the fluorescence intensity of CypA itself competes with CsA, [CsA] for binding Cyp-A, [CypA], then a plot of the corrected fluorescence, f corr , versus the concentration of competing ligand, in the presence of a fixed amount of [CsA], can be fitted to Eq. (4) to give the apparent K i for the competing ligand. Such data were least squares fit to Eq. (4) using Kaleidagraph v3.6 software: 

Between approximately 1000 and 3200 RU of pure His-CypA could be captured on an NTA sensor surface using recommended protocols (Fig. 1A) . However, the affinity of the single hexahistidine tag for the Ni 2+ -NTA moiety on the chip is relatively weak (K d $ 0.5-3 lM [12] ), and immediately after the injection phase (Fig. 1A , phase a) is halted there is significant and steady baseline drift due to dissociation of the histidine tag from the chip surface (Fig. 1A, phase b) . All of the initially immobilized protein could be dissociated from the surface by washing with running buffer for approximately 2 h (Fig. 1A, *) . Such a sensor surface is not really stable enough for the determination of binding constants, especially for potentially weakly binding and low-molecular weight ligands.

Complete elimination of protein dissociation was achieved by rapidly following the capture of His-CypA on the NTA surface with a brief covalent stabilization phase (Fig. 1B) . After saturation responses were achieved (Fig. 1B, phase a) , a 30-s burst of surface activation and coupling (with a mixture of NHS/EDC, Fig. 1B , phase c) was quickly followed by a 30-s injec-tion of ethanolamine (Fig. 1A , phase d) to quench the unreacted succinimide esters remaining on the sensor surface (see Materials and methods). The dissociation of His-CypA from the sensor surface was completely arrested. Even after washing the surface exhaustively (P3 h) with running buffer, the response level remained constant (Fig. 1B) .

Using standard protocols, significant levels ($1000-5000 RU) of pure CypA and biotinylated CypA could also be covalently immobilized on activated CM5 and SA sensor surfaces, respectively (data not shown) [35] (see Materials and methods). These surfaces exhibited stable response levels with no baseline drift (data not shown). Activity of NTA-captured, covalently stabilized His-CypA Next, we wanted to assess the activity of the immobilized protein on the sensor surfaces. This was performed by passing saturating concentrations (>0.95 lM) of the naturally occurring tight binding ligand (K d $ 10-40 nM, Table 1 ) CsA over the sensor surfaces. CsA is a cyclic undecapeptide fungal metabolite with immunosuppressive properties that is widely used in transplant surgery [13] . The surface activity of various sensor surfaces is represented graphically in Fig. 2 . His-CypA captured and covalently stabilized on the NTA surface retained very high levels of activity, typically in excess of 85% ( Fig. 2A) . In comparison, the immobilized protein on the surface of the CM5 chips retained only approximately 5% activity (Fig. 2B) . Similarly, only 7% activity was retained by biotinylated CypA immobilized on an SA sensor surface (Fig. 2B) . Pure CypA was biotinylated using standard primary amine coupling chemistries before immobilization on the SA chip (see Materials and methods).

We used the covalently stabilized His-CypA sensor surfaces to further characterize the interaction of CypA with CsA. Globally fitting a kinetic model where a 1:1 complex is formed between His-CypA and CsA to data similar to those illustrated in Fig. 3A gave very good fits. The mean on-rate constant (k +CsA ) was 0.53 ± 0.1 lM À1 s À1 , and the mean off-rate constant (k ÀCsA ) was 0.012 ± 0.01 s À1 , giving an equilibrium dissociation constant (K dCsA ) of 23 ± 6 nM ( Table 1 ). The inclusion of mass transport considerations had only a very minor effect on the kinetic constants extracted from the data. Very similar values for K dCsA were obtained from steady-state response calculations, where the mean K dCsA value was 18.5 ± 6 nM ( Fig. 3B and Table 1 ). These values determined by SPR for the equilibrium dissociation constant for CsA binding to His-CypA are in good agreement with those determined from solution fluorescence titration experiments (K dCsA = 29 ± 6 nM, Fig. 4) and with values determined by other methods in the literature (for a representative comparison, see Table 1 ).

Our values for the apparent kinetic rate constants, determined from SPR experiments, also agree well with those determined from modeling the time course of the CsA binding-induced fluorescence enhancement ( Fig. 4B and Table 1 ) and with those recently published for the interaction of the CypD isoform and CsA ana- Table 1 Representative equilibrium dissociation (K dCsA ), on-rate constant (k +CsA ), and off-rate constant (k ÀCsA ) for the interaction of CsA with CypA, His-CypA, or CypD, determined from this study and other studies K Eq dCsA (nM) K Kin dCsA (nM) k +CsA (lM À1 s À1 ) k ÀCsA · 10 À3 (s À1 ) SPR His-CypA a 18.5 ± 6 23 ± 6 0.53 ± 0. Note. K Eq dCsA values were determined from steady-state experiments using the indicated technique. K Kin dCsA values were calculated from kinetic assays using the determined on-rate (k ÀCsA ) and off-rate (k +CsA ) constants from SPR experiments or from intrinsic tryptophan fluorescence time course experiments using the formula K dCsA = k ÀCsA /k +CsA . a Values (means ± SE, where n P 3) determined from this study. b [39] . c Values determined by SPR in [32] using CsA and either human CypD or a fusion of O 6 -alkylguanine-DNA-alkyltransferase and CypD (TCypD-hAGT). d [43] . e Values determined using ITC in [36] . f Values determined using ITC in [44] . g K i,app values determined using a PPIase enzymatic assay performed as described in [45, 46] . h K i,app values determined using a PPIase enzymatic assay performed as described in [45, 47] . lyzed by SPR [32] . In the study by Huber and coworkers [32] , the apparent on and off rates for CsA binding to CypD ranged between 0.2 and 0.5 lM À1 s À1 (on rate) and between 0.003 and 0.006 s À1 (off rate), giving a mean K dCsA of 12 nM [32] (Table 1) . Our sensor surfaces generated by this method gave responses that were very reproducible. Three independent runs of 25 nM CsA over the same sensor surface 4 h apart gave sensorgrams that are virtually superimposable (Fig. 3C ). Locally fitting each curve gave essentially identical on-and off-rate constants (data not shown). In addition to a high level of run reproducibility, the saturation responses with CsA varied minimally over the course of many hours (Fig. 3D ). Essentially the same response was observed for P38 h.

These results indicate that the simple protocol of first capturing His-CypA on a Ni 2+ -NTA chip and then briefly covalently stabilizing it, using standard primary amine coupling chemistries, generates a very stable and active sensor surface. They further suggest that in terms of binding affinities and kinetics, His-CypA is interacting with CsA in a manner similar to that in free solution.

We have previously generated several novel combinatorial libraries of small molecule inhibitors of human CypA (K. Malone, C. Dunsmore, N.J. Turner, unpublished results). We wanted to test whether the His-CypA sensor surfaces described in the above sections could be used to facilitate the primary screening of these smallmolecule (M r $300-500 Da) ligand libraries. Fig. 5A graphically illustrates the equilibrium response signal attained for 120 lM of the respective ligands. These compounds were chosen as positive controls to assess the sensor surface because they have previously been shown to bind to CypA with K d values in the 10-to 100-lM range ( Table 2 ). One problem encountered was that the ligands tested have limited solubility in aqueous buffers, and this led to significant variation in the response signals for repeat runs of the same ligand. In addition, large ''spikes'' in the RU signal at the beginning and end of the injection phases further hampered reliable direct detection (data not shown). These can likely be attributed to a bulk phase shift given that there are large amounts of insoluble material present during the mobile phase as it passes over the chip surface with protein attached. Ethanol (2%) was added to the running buffer to help ligand solubility for all runs. Higher concentrations of either ethanol or methanol resulted in protein denaturation and rapid loss of activity on the sensor surface on subsequent runs (data not shown). DMSO was avoided as a solvent because this binds to CypA itself, albeit very weakly [31] . Nevertheless, direct binding to His-CypA could be detected for the ligands KM19, KM184, KM198, and CD291/02 (Fig. 5A) .

We also used a competition binding assay in which a fixed concentration of CsA (25 nM, a concentration near the K dCsA value, Table 1 ) was passed over the . The activity of the protein coupled to the surface varied minimally between 85 and 95%; the specific activity of each surface is indicated. The number in parentheses below each sensor surface number is the total amount of protein (in RU) finally stabilized on the sensor surface. (B) A similar graphical representation comparing the theoretical maximum RU signal (white bars) with the experimental maximum RU signal (black bars) of CM5 and SA sensor surfaces generated as described. The average level of activity retained for the CM5 surfaceimmobilized CypA was 6.5%, and the level of activity retained for the single SA surface-immobilized CypA was 7%. These values appear to be relatively unaffected by the total amount of protein initially deposited on the sensor surface. In all cases, the experimental RU max value was generated by passing 1.1 lM CsA in 10 mM Hepes (pH 7.4), 150 mM NaCl, 3 mM EDTA, 0.005% surfactant P20, and 2% ethanol over the surface. sensor surface in the absence or presence of increasing concentrations of the small-molecule inhibitors. Fig. 5B illustrates a representative set of sensorgrams from such experiments. The sensorgrams obtained from such assays were generally less noisy than those obtained in direct binding experiments. Three small molecules (KM184, KM19, and KM198) were tested and competed with CsA for binding to CypA with K d values in the micromolar range ( Table 2 ). The rank ordering of the compounds from tightest to weakest binding was as follows: KM184, KM19, and KM198 with K d values of 36, 46.9, and 73.6 lM, respectively (Table 2) . Relatively similar K d values, and (more important) the same rank order, were obtained for these three compounds in solution by a fluorescence competition assay (data not shown) ( Table 2 ).

Covalent coupling of proteins via primary amines is frequently the method of choice for immobilization in SPR assays, generating sensor surfaces with high ligand density and no baseline drift. Our results here illustrate, however, that CypA is not amenable to direct covalent linkage using primary amines. Protein activity levels for CypA directly immobilized on CM5 surfaces were only approximately 5%. This activity was unaffected by the initial immobilization levels; immobilization of between 1000 and 5000 RU of untagged CypA gave essentially the same low levels of activity (Fig. 2B) . The X-ray structure indicates that the majority of CypAÕs 16 primary amines (15 lysine residues and the N terminus) are surface exposed [33] and probably available for direct covalent linkage. However, the surface electrostatic potential of CypA (Fig. 6) illustrates that the front face (the CsA binding face) is strikingly basic, whereas the rear face is much more acidic in character. Under the solution conditions (pH 4.9) used during the immobilization process, the surface charge potential of CypA seems likely to force the molecule to orient itself with the CsA binding surface oriented downward toward the activated chip surface. Thus, most of the covalent linkage would occur via residues on the CsA binding surface, resulting in severe steric occlusion of the binding of CsA. The activity levels of CypD immobilized by direct covalent linkage, under similar conditions and with similar final protein immobilization levels, were approximately 45 to 65% [32] . However, CypD does not possess the same markedly polarized surface charge potential of CypA; thus, coupling via primary amines is unlikely to take place predominantly on the CsA binding face.

In addition to these structural/steric considerations, the pH of 4.9 used during the initial immobilization phase likely further contributes to the low protein activity on CM5 chips. The K dCsA at pH 4.9 was 150 nM ± 34 nM (determined from fluorescence titration experiments [data not shown]), compared with 26 ± 9 nM at pH 7.5 ( Fig. 4 and Table 1 ). Similar acidic pH shift-dependent affinity loss has been observed in isothermal titration calorimetry (ITC) experiments with CypA and CsA [36] , attributed to protein protonation effects. The protein recovers only partially; when the pH was raised again to 7.5, the K dCsA for the same sample of CypA as above was 57 ± 12 nM (data not shown). It is unclear why protonation would not be reversible other than some partial irreversible denaturation due to the acidic solution conditions that for CypA does occur at a pH below 5 [17, 36] .

In contrast to these observations, the simple protocol described here for immobilizing and covalently stabilizing His-CypA yields a very stable (P38 h), highly active (P85% activity), and sensitive sensor surface. Using the N-terminal histidine tag to first capture CypA on the NTA sensor surface seems to provide a measure of orientation for the immobilized protein. The 10-amino acid linker between the hexahistidine tag and the start of the CypA sequence likely lifts CypA away from the active chip surface, preventing coupling to random lysine residues that hinder/prevent CsA binding. The only primary amine near enough to the activated sensor surface is the N terminus, and the entropic effects of being immobilized near the surface via the histidine tag may provide specificity for coupling essentially only to this primary amine. Thus, the protein is covalently immobilized but is kept active and sterically competent for CsA binding.

It is interesting to note that the apparent on-rate constants for CsA binding to either CypA or CypD Note. K dBia values were calculated from the off-and on-rate constants (k À and k + , respectively) determined from SPR competition experiments in the presence of 25 nM CsA and using the formula K dBia = k À /k + . Mean K dFluor values were determined from competition fluorescence titration experiments (see Materials and methods) (data not shown). isoforms determined in this study ($0.5 lM À1 s À1 ) and in that by Huber and coworkers ($0.3 lM À1 s À1 ) [32] are somewhat slower than a diffusion limited on rate ($10 lM À1 s À1 ), as one might have expected for a relatively small molecule such as CsA (M r $1200 Da). The hydrophobic cyclic undecapeptide CsA is in multistate equilibrium between two extreme conformations influenced by the solution conditions. In aqueous solution, CsA tends more to adopt a compact closed conformation [37] , whereas cyclophilins bind tightly only to an open conformation. The slower than diffusion limit on-rate constants might reflect the CsA conformational equilibrium. The off-rate constant for the CypA:CsA interaction appears to be two-to threefold quicker than that between CsA and CypD (0.012 and 0.004 s À1 , respectively [32] ) ( Table 1 ). This slight difference may reflect genuine differences in the molecular details of the interaction between CsA and these two differentially localized, functionally distinct cyclophilin isoforms. CypA is ubiquitously localized in mammalian cytoplasm [13] , whereas CypD is a mitochondrial-targeted PPIase [38] . Nevertheless, the binding constants obtained in this study for the equilibrium dissociation constant for CsA binding to His-CypA by SPR agree well with the values for the same interaction determined by a variety of experimental approaches, including ITC, intrinsic tryptophan fluorescence, and PPIase enzymatic assays ( Table 1 ). This does suggest that the protein molecules immobilized on the chip surface behave in a manner comparable to that of protein molecules in solution, at least in terms of binding to CsA. The results in this study illustrate the sensitivity of SPR in that we were able to reliably detect the direct binding of small-molecular weight ligands (300-500 Da) (Fig. 5A) . However, the on rates for these small-molecule inhibitors are very slow ($0.4-0.7 · 10 À3 lM À1 s À1 ) ( Table 2) , orders of magnitude slower than even CsA itself. Although they appear to bind specifically to CypA, there may be some conformational constraint on these small molecules that requires a degree of ''induced fit'' in terms of their binding mechanism. Structural data of these cyclophilin-ligand complexes are not available, and the bound conformation of the ligands is not known. Poor solubility, aggregation, and/or nonspecific binding of the ligands may also play a role in the calculation of their apparently slow on rate, and it is possible that the functional ligand concentration, competent to interact with the immobilized His-CypA, is less than the expected measured total. This would result in the apparent on rates being faster and the equilibrium dissociation constants being tighter. However, this is unlikely to cause orders of magnitude changes in these kinetic constants. It is reassuring to note that despite the slow calculated on rates, the apparent K d values for these ligands and the rank order of their relative affinities determined from the competition experiments agree with the values determined by intrinsic tryptophan fluorescence experiments.

This study is the first to use SPR to analyze smallmolecule-CypA binding interactions. Indeed, this article also provides the first published values for the on and off rates of the CypA-CsA interaction. The protocol is simple and yields a sensor with high levels of immobilized protein activity that leads to sensors with a high degree of sensitivity. There are relatively few studies in the literature that report the use of SPR in the study of CypA and its binding partner interactions [28] [29] [30] 32, [39] [40] [41] [42] . In early work analyzing the interaction of CypA and CsA and the conformational requirements required for this interaction [39] [40] [41] , CsA (conjugated to bovine serum albumin [BSA]) and not CypA, was immobilized on the sensor surface [39] . Although interactions between CypA, directly coupled to the sensor surface, and protein binding partners have been published (e.g., HIV-1 capsid [28] , HIV-1 Vpr [42] , SARS coronavirus [30] ), the activity and sensitivity of a sensor surface needed to detect binding in these much larger molecules are significantly less than those required to detect small molecules.

A further advantage of the surfaces generated in this study is that they are very unlikely to exhibit problems with steric hindrance due to the ''overcrowding'' of molecules on the surface, a potential problem with immobilization of relatively high amounts of protein. The average level of His-CypA finally stabilized on the NTA sensor surfaces in this study was approximately 1000 RU. This corresponds to approximately 3 · 10 10 protein molecules within a volume of approximately 1 · 10 14 nm 3 and provides an average intermolecular spacing between each CypA molecule of more than 100 Å This rather sparse but stable binding arrangement may explain the good agreement in the values for the kinetic and equilibrium constants among the SPR data, the solution fluorescence data, and other published data determined by other techniques.

The results in this study clearly indicate that CypA is not amenable to direct covalent coupling to SPR sensors via primary amines. Conversely, our study provides a good general methodology for generating a highly sensitive, stable, and reusable sensor surface of His-CypA that interacts with CsA in a manner essentially indistinguishable from that determined by other experimental approaches. Furthermore, it provides a good methodology that would allow the development of a mediumthroughput screen for small molecules ligands/inhibitors of CypA that may provide useful leads in developing new drugs for the treatment of diseases such as HIV and malaria.

Kinetic, equilibrium, and thermodynamic analysis of macromolecular interactions with Biacore

Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition

Surface plasmon resonance applied to DNA-protein complexes

A survey of the year 2002 commercial optical biosensor literature

Implementing surface plasmon resonance biosensors in drug discovery

Surface plasmon resonance characterization of drug/liposome interactions

Probing the mechanism of drug/ lipid membrane interactions using Biacore

Analysis of small-molecule interactions using Biacore S51 technology

Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology

Optimizing the hit-to-lead process using SPR analysis

Integration of surface plasmon resonance with mass spectrometry: automated ligand fishing and sample preparation for MALDI MS using a Biacore 3000 biosensor

Biacore analysis of histidine-tagged proteins using a chelating NTA sensor chip

Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity-targets-functions

Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors

Cyclosporin-binding proteins of Plasmodium falciparum

Structures of immunophilins and their ligand complexes

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

The impact of immunosuppressive drugs on the analysis of T cell activation

Cyclosporin analogs modified in the 3,7,8-positions: substituent effects on peptidylprolyl isomerase inhibition and immunosuppressive activity are nonadditive

X-ray structures and analysis of 11 cyclosporin derivatives complexed with cyclophilin A

Synthesis of non-immunosuppressive cyclophilin-binding cyclosporin A derivatives as potential anti-HIV-1 drugs

Synthesis and neurotrophic activity of nonimmunosuppressant cyclosporin A derivatives

Substitution in position 3 of cyclosporin A abolishes the cyclophilin-mediated gain-of-function mechanism but not immunosuppression

In vitro antiparasitic activity of cyclosporin A analogs on Trypanosoma cruzi

Unexpected side chain effects at residue 8 of cyclosporin A derivatives allow photoswitching of immunosuppression

Anti-inflammatory effects of a cyclosporin receptor-binding compound, D-43787

Synthesis and biological evaluation of non-peptidic cyclophilin ligands

Molecular recognition in the HIV-1 capsid/cyclophilin A complex

The chaperone activity of protein disulfide isomerase is affected by cyclophilin B and cyclosporin A in vitro

Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A

Enzymatic and structural characterization of non-peptide ligand-cyclophilin complexes

SPRbased interaction studies with small molecular weight ligands using hAGT fusion proteins

Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy

Tryptophan microstate reshuffling upon the binding of cyclosporin A to human cyclophilin A

Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors

Thermodynamic characterization of the interaction of human cyclophilin 18 with cyclosporin A

Conformational polymorphism of cyclosporin A, Structure

cDNA cloning of rat mitochondrial cyclophilin

Interaction of cyclosporin A with an Fab fragment or cyclophilin: affinity measurements and time-dependent changes in binding

Interaction of cyclosporin A and two cyclosporin analogs with cyclophilin: relationship between structure and binding

Analysis of cyclosporin interactions with antibodies and cyclophilin using the BIAcore

Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression

Peptidyl-prolyl cis-trans-isomerase from Escherichia coli: a periplasmic homolog of cyclophilin that is not inhibited by cyclosporin A

Calorimetric measurements of the complexation of cyclosporine A, ascomycin, fujimycin, and rapamycin with lithium-chloride and with an immunophilin

Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay

A single Trp121 to Ala121 mutation in human cyclophilin alters cyclosporin A affinity and peptidyl-prolyl isomerase activity

Lithium chloride perturbation of cis-trans peptide bond equilibria: effect on conformational equilibria in cyclosporin-A and on time-dependent inhibition of cyclophilin

We thank John Butler of Biacore for invaluable technical support, advice, and an inordinate amount of patience. This work was supported by the MRC, Biacore, the Wellcome Trust, and the Edinburgh Protein Interaction Centre (EPIC).